Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 8, 2014

 

 

InfuSystem Holdings, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-35020   20-3341405

(State or other jurisdiction

of incorporation or organization)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

31700 Research Park Drive

Madison Heights, Michigan 48071

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (248) 291-1210

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07. Submission of Matters to a Vote of Security Holders

On May 8, 2014, the Company held its 2014 Annual Meeting of Stockholders (the “Annual Meeting”). Of the 22,161,129 shares of the Company’s common stock outstanding and entitled to vote as of the March 14, 2014, record date, 17,961,461 shares were present at the Annual Meeting in person or by proxy. The following proposals were voted on at the Annual Meeting:

Proposal 1—The stockholders elected all of the Company’s nominees for election to the Company’s Board of Directors. The results of the number of shares voted were as follows:

 

Director Name

   For      Withheld      Broker
Non-Votes
 

David Dreyer

     10,706,812         1,974,277         5,280,362   

Gregg Lehman

     11,159,954         1,521,135         5,280,362   

Ryan Morris

     8,899,887         3,781,202         5,280,362   

Eric Steen

     11,230,031         1,451,058         5,280,362   

Joseph Whitters

     10,686,812         1,994,277         5,280,362   

Wayne Yetter

     11,241,017         1,440,072         5,280,362   

Proposal 2—Approval of the adoption of the Company’s Employee Stock Purchase Plan was approved based on the number of shares voted as follows:

 

     Shares  

For:

     10,514,144   

Against:

     2,145,970   

Abstain:

     20,985   

Broker non-votes:

     5,280,362   

Proposal 3—Approval of the adoption of the Company’s Equity Plan was approved based on the number of outstanding shares voted as follows:

 

     Shares  

For:

     11,674,011   

Against:

     770,522   

Abstain:

     236,566   

Broker non-votes:

     5,280,362   


Proposal 4—Approval, by advisory vote, on the compensation of the Company’s named executive officers was approved based on the number of shares voted as follows:

 

     Shares  

For:

     10,520,792   

Against:

     1,317,002   

Abstain:

     843,305   

Broker non-votes:

     5,280,362   

Proposal 5—The stockholders ratified the appointment of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2014. The results of the number of shares voted were as follows:

 

     Shares  

For:

     17,413,247   

Against:

     507,326   

Abstain:

     40,888   

Broker non-votes:

     —     


Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    INFUSYSTEM HOLDINGS, INC.
    By:   /s/ Jonathan P. Foster
      Name: Jonathan P. Foster
      Title: Chief Financial Officer

Dated: May 8, 2014